Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: BIOLOGICAL: Allogeneic GM-CSF-secreting breast cancer vaccine|DRUG: Trastuzumab|DRUG: Cyclophosphamide
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: American Cancer Society, Inc.|Avon Foundation|Cancer Treatment Research Foundation|The Commonwealth Fund|United States Department of Defense|Genentech, Inc.